AfaSci
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $17.5M
Overview
AfaSci Inc. is a privately held, San Francisco Bay Area-based biopharmaceutical company founded in 2008. It operates through integrated subsidiaries focused on developing novel small molecule therapeutics for central nervous system disorders, providing preclinical contract research services, and commercializing automated rodent behavioral monitoring instruments. The company's lead clinical candidate, AFA-281, is a novel, orally available small molecule targeting chronic pain and epilepsy.
Small Molecules
Funding History
2Total raised:$17.5M
Series A$15M
Seed$2.5M